Effects of exenatide on postprandial vascular endothelial dysfunction in type 2 diabetes mellitus
Conclusions:
Exenatide inhibited postprandial vascular endothelial dysfunction after the meal loading test, suggesting that exenatide has a multiphasic anti-atherogenic action involving not only glucose but also lipid metabolism.Trial registrationClinicalTrials.gov: UMIN000015699.
Source: Cardiovascular Diabetology - Category: Cardiology Authors: Keiichi TorimotoYosuke OkadaHiroko MoriTakashi OtsukaMayuko KawaguchiMegumi MatsudaFumi KunoKei SugaiSatomi SonodaMaiko HajimeKenichi TanakaTadashi AraoYoshiya Tanaka Source Type: research
More News: Byetta | Cardiology | Cardiovascular | Cholesterol | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Heart | Study